Pulse Biosciences develops medical devices based on bioelectric technology for treating various conditions. The company's product portfolio includes systems for skin lesion removal, soft tissue procedures in the operating room, and cardiac applications including atrial fibrillation treatment through both surgical and catheter-based approaches, along with a software platform to support clinical use. Founded in 2014 and based in Miami, Florida, the company was previously named Electroblate before adopting its current name in 2015.

entry readiness 2 · NOT READY · exit proximity 35

Value area 20.74–51.27 · 21% of 120d volume overhead · moderate overhead